期刊文献+

超声造影参数成像在甲状腺微小乳头状癌鉴别诊断中的应用价值 被引量:13

The value of parametric imaging of contrast-enhanced ultrasound in differential diagnosis of papillary thyroidmicrocarcinoma
下载PDF
导出
摘要 目的:探讨超声造影(CEUS)参数成像在甲状腺微小乳头状癌(PTMC)鉴别诊断中的应用价值。方法:回顾性分析经手术切除的60个甲状腺结节(最大径≤1.0 cm)的超声造影资料,用QontraXt软件定量分析结节灌注峰值(Peak)、达峰时间(TP)、灌注率(Shapness)、曲线下面积(AUC);据手术病理结果分为良性组(n=28)和恶性组(n=32),分析CEUS参数在PTMC鉴别诊断中的价值。结果:超声造影定量分析结果显示,恶性组Peak、AUC显著小于良性组,两组比较差异有统计学意义(P<0.05);TP、Shapness良恶性组之间比较差异无统计学意义(P>0.05)。Peak、AUC诊断PTMC的ROC曲线下面积分别为0.819和0.738,最佳截断值(Cutoff值)分别为50.25和9.5;Peak诊断PTMC的敏感性、准确度高于AUC。结论:CEUS参数成像在PTMC的鉴别诊断中具有重要价值,其中Peak的价值最大,可作为鉴别PTMC的重要参考指标。 Objective:To investigate the value of parametric imaging of contrast-enhanced ultrasound(CEUS)in differential diagnosis of papillary thyroid microcarcinoma(PTMC).Methods:The CEUS data of 60 thyroid nodules(maximum diameter<1.0 cm)via surgical resection were retrospectively analyzed.The Peak,the time to peak(TP),the Shapness,the area under the curve(AUC)of nodules were quantitatiely analyzed by QontraXt software.According to the pathological results of surgery,the nodules were divided into benign group(n=28)and malignant group(n=32).Results:Peak and AUC were significantly lower in malignant group than those in benign group,and the difference was statistically significant(P<0.05).There was no statistically significant difference in TP and Shappness between benign group and malignant group(P>0.05).The area under the ROC curve of Peak and AUC in diagnosing PTMC were respectively 0.819 and 0.738,the best cutoff value were respectively 50.25 and 9.50.The sensitivity and accuracy of Peak in diagnosing PTMC were higher than AUC.Conclusion:The parametric imaging of CEUS has important value in the differential diagnosis of PTMC,among which Peak has the best value and can be used as an important reference index.
作者 王双龙 吕镔 李龙 马香玲 赵蕊 高小红 庞慧 WANG Shuanglong;LV Bin;LI Long(Department of Ultrasound,the First People's Hospital of Jining,Shandong Province,Jining 272011)
出处 《陕西医学杂志》 CAS 2020年第5期599-602,共4页 Shaanxi Medical Journal
基金 山东省济宁市科技助推新旧动能转换计划项目(2017SMNS011)。
关键词 甲状腺结节 甲状腺微小乳头状癌 诊断 超声造影 时间强度曲线 定量参数 Thyroid nodule Papillary thyroid microcarcinoma Diagnosis Contrast-enhanced ultrasound Time-activity curve Quantitative parameters
  • 相关文献

参考文献8

二级参考文献88

  • 1American Thyroid Association (ATA) Guidelines Taskforce on Thy- roid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American thyroid association manage- ment guidelines for patients with thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2009, 19(11):1167-1214.
  • 2Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid as- sociation management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid as- sociation guidelines task force on thyroid nodules and differentiat- ed thyroid cancer[J]. Thyroid, 2016, 26(1):1-133.
  • 3Tuttle RM, Haddad RI, Ball DW, et al. Thyroid carcinoma, version 2.2014[J]. J Natl Compr Canc Netw, 2014, 12(12):1671-1680.
  • 4Xing MZ. Molecular pathogenesis and mechanisms of thyroid can- cer[J]. Nat Rev Cancer, 2013, 13(3):184-199.
  • 5De Biase D, Gandolfi G, Ragazzi M, et al. TERT promoter mutations in papillary thyroid microcarcinomas[J]. Thyroid, 2015, 25(9):1013- 1019.
  • 6Ito Y, Miyauchi A, Inoue H, et al. An observational trial for papillary thyroid microcarcinoma in Japanese patients[J]. World J Surg, 2010, 34(1):28-35.
  • 7Ito Y, Uruno T, Nakano K, et al. An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid [J]. Thyroid, 2003, 13(4):381-387.
  • 8Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and recurrence of papillary thyroid cancer[J]. J Clin Oncol, 2015, 33(1):42-50.
  • 9Jiang LH, Chen C, Tan Z, et al. Clinical characteristics related to central lymph node metastasis in cN0 papillary thyroid carcinoma: a retro- spective study of 916 patients[J]. Int J Endocrinol, 2014, 2014:385787.
  • 10Ito Y, Fukushima M, Higashiyama T, et al. Tumor size is the strongest predictor of microscopic lymph node metastasis and lymph node recurrence of NO papillary thyroid carcinoma[J]. Endocr J, 2013, 60 (1):113-117.

共引文献481

同被引文献126

引证文献13

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部